Director Mario Schlosser Sells $22.8M in Oscar Health Stock
OSCR has more than doubled off its 52-week low of $10.69.
Summary
Director Mario Schlosser sold $22.8 million of Oscar Health stock after exercising options, continuing a broader insider selling trend.
Key Events · Ownership and Investor Activity · OSCR
-
Director Sells $22.8M in Stock
Mario Schlosser exercised 750,000 options at $9.75 and sold all resulting Class A shares for $22,822,500 on August 27-28, 2026.
-
Full Position Liquidated
The sale represents the complete liquidation of the exercised shares, with post-transaction direct holdings of 3,140,000 shares.
-
Broader Insider Selling Trend
Five insiders have sold over $103 million in open-market transactions over the last 90 days, including CFO Richard Scott Blackley's $595,125 sale on August 18.
-
Sale Price Near Recent Highs
Shares were sold at weighted average prices of $30.34 and $30.79, near the current price of $30.17.
Analysis · OSCR · Finance
Director Mario Schlosser exercised 750,000 options at $9.75 and immediately sold all resulting shares for $22.8 million on August 27-28. The sale continues a pattern of insider distribution at Oscar Health — five insiders have sold over $103 million in the last 90 days, including the CFO's $595k sale on August 18. While option exercises are routine, the immediate liquidation of the entire position at prices near $30 suggests limited near-term upside conviction from a board member.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1387 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.51%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OSCR was trading at $30.17 on NYSE in the Finance sector, with a market capitalization of approximately $8.2B. The 52-week trading range was $10.69 to $33.55. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.